Product information

Current status:

Cancelled Post Market

Current status date:

2000-08-03

Original market date: ^{See footnote 1}

1991-12-31

Product name:

TAZIDIME ADD-VANTAGE INJ 1.0GM/VIAL

DIN:

00887129 Electronic product monograph is not available

Company:

ELI LILLY CANADA INC
SUITE 900 Exchange Tower, 130 King Street West
Toronto
Ontario
Canada M5X 1B1

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

08:12.06.12 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

J01DD02 CEFTAZIDIME

Active ingredient group (AIG) number:^{See footnote5}

0116900004